An update on malaria prevention, diagnosis and treatment for the returning traveller

Blood Reviews

Volumn 21, Issue 2, 2007, Pages 73-87

  Gkrania Klotsas, Effrossyni ^a   Lever, Andrew M L ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Malaria; Malaria diagnosis; Malaria prevention; Malaria treatment; Returning traveller

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISIN; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; CHOLERA VACCINE; DAPSONE; DIHYDROARTEMISININ; DOXYCYCLINE; FANSIDAR; FOLIC ACID ANTAGONIST; HALOFANTRINE; HYDROXYCHLOROQUINE SULFATE; INSECT REPELLENT; MALARIA VACCINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUINIDINE; QUININE; RABIES VACCINE; SULFONAMIDE; TAFENOQUINE; TYPHOID VACCINE; UNINDEXED DRUG;

ABDOMINAL PAIN; ANGER; ANTIGEN DETECTION; ARTICLE; AVOIDANCE BEHAVIOR; AWARENESS; BED NET; BLURRED VISION; COMPLIANCE (PHYSICAL); COMPUTER ASSISTED DIAGNOSIS; DEPRESSION; DRUG SUBSTITUTION; EMPORIATRICS; ESOPHAGITIS; FATIGUE; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL SYMPTOM; GOLD STANDARD; HEADACHE; HUMAN; INSOMNIA; LACTATION; MALARIA; MALARIA CONTROL; MOSQUITO; NAUSEA; PHOTOSENSITIVITY; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PSORIASIS; RECOMMENDED DRUG DOSE; RETINOPATHY; SIDE EFFECT; SKIN MANIFESTATION; TRAVEL; TREATMENT PLANNING; VOMITING;

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA; MALARIA VACCINES; SESQUITERPENES; TRAVEL;

EID: 33947231604     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2006.03.004     Document Type: Article

References (108)

1. White N.J. Malaria. In: Cook G.C., and Zumla A.I. (Eds). Manson's Tropical Diseases. 21st ed. (2002), W.B. Saunders Company 1205-1295 November
2. Hay S.I., Guerra C.A., Tatem A.J., Noor A.M., and Snow R.W. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis 4 6 (2004) 327-336
3. Newman R.D., Parise M.E., Barber A.M., and Steketee R.W. Malaria-related deaths among U.S. travellers, 1963-2001. Ann Intern Med 141 7 (2004) 547-555
4. Eliades M.J., et al. Malaria surveillance-United States, 2003. MMWR Surveill Summ 54 2 (2005) 25-40
5. Newman R.D., Barber A.M., Roberts J., Holtz T., Steketee R.W., and Parise M.E. Malaria surveillance-United States, 1999. MMWR Surveill Summ 51 1 (2002) 15-28
6. Causer L.M., Newman R.D., Barber A.M., et al. Malaria surveillance-United States, 2000. MMWR Surveill Summ 51 SS05 (2002) 9-23
7. Filler S., Causer L.M., Newman R.D., Barber A.M., Roberts J.M., MacArthur J., et al. Malaria surveillance-United States, 2001. MMWR Surveill Summ 52 5 (2003) 1-14
8. Shah S., Filler S., Causer L.M., Rowe A.K., Bloland P.B., Barber A.M., et al. Malaria surveillance-United States, 2002. MMWR Surveill Summ 53 1 (2004) 21-34
9. Steffen R., Fuchs E., Schildknecht J., Naef U., Funk M., Schlagenhauf P., et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 341 8856 (1993) 1299-1303
10. Kain K.C., MacPherson D.W., Kelton T., Keystone J.S., Mendelson J., and MacLean J.D. Malaria deaths in visitors to Canada and in Canadian travellers: a case series. CMAJ 164 5 (2001) 654-659
11. Harling R., Crook P., Lewthwaite P., Evans M., Schmid M.L., and Beeching N.J. Burden and cost of imported infections admitted to infectious diseases units in England and Wales in 1998 and 1999. J Infect 48 2 (2004) 139-144
12. Greenwood B.M., Bojang K., Whitty C.J., and Targett G.A. Malaria. Lancet 365 9469 (2005) 1487-1498
13. Rose S.R. International travel health guide. 13th ed. (2002), Travel Medicine, Inc., Northampton, MA
14. Bradley D.J., and Bannister B. Health Protection Agency Advisory Committee on Malaria Prevention for UK Travellers. Guidelines for malaria prevention in travellers from the United Kingdom for 2003. Commun Dis Public Health 6 3 (2003) 180-199
15. Angus B.J. Malaria on the World Wide Web. Clin Infect Dis 33 5 (2001) 651-661 Epub 2001 Jul 30
16. Health Information for International Travel, 2005-2006, http://www.cdc.gov/travel/yb/.
17. Molineaux L., Muir D.A., Spencer H.C., and Wernsdorfer W.H. The Epidemiology of Malaria and its Measurement. In: Wernsdorfer W.H., and McGregor I. (Eds). Malaria: Principles and Practice of Malariology (1988), Churchill Livingstone, Edinburgh 999-1090
18. MacDonald G. The epidemiology and control of malaria (Oxford medical publications) (1957), Oxford University Press
19. Over M., Bakote'e B., Velayudhan R., Wilikai P., and Graves P.M. Impregnated nets or DDT residual spraying? Field effectiveness of malaria prevention techniques in Solomon islands, 1993-1999. Am J Trop Med Hyg 71 2 Suppl (2004) 214-223
20. D'Alessandro U., Olaleye B., Langerock P., Bennett S., Cham K., Cham B., et al. The Gambian National Impregnated Bed Net Programme: evaluation of effectiveness by means of case-control studies. Trans R Soc Trop Med Hyg 91 6 (1997) 638-642
21. Etang J., Chandre F., Guillet P., and Manga L. Reduced bio-efficacy of permethrin EC impregnated bednets against an Anopheles gambiae strain with oxidase-based pyrethroid tolerance. Malar J 3 1 (2004) 46
22. Bell J.W., Veltri J.C., and Page B.C. Human Exposures to N, N-diethyl-m-toluamide insect repellents reported to the American Association of Poison Control Centers 1993-1997. Int J Toxicol 21 5 (2002) 341-352
23. Sudakin D.L., and Trevathan W.R. DEET: a review and update of safety and risk in the general population. J Toxicol Clin Toxicol 41 6 (2003) 831-839
24. [No authors listed] Picaridin-a new insect repellent. Med Lett Drugs Ther. 2005;47(1210):46-7.
25. Robb-Nicholson C. By the way, doctor. DEET makes a mess of my fly fishing gear. I've heard there are some new mosquito repellents that don't contain DEET. Are they any good?. Harv Womens Health Watch 12 12 (2005) 8
26. Baird J.K. Effectiveness of antimalarial drugs. N Engl J Med 352 15 (2005) 1565-1577
27. White N.J. The treatment of malaria. N Engl J Med 335 (1996) 800-806
28. Stephen R., and Jong E.C. Travellers' and Immigrants' Health. In: Guerrant R.L., Walker P.H., and Wyler P.F. (Eds). Tropical Infectious Diseases: Principles, Pathogens and Practice (1999), Churchill Livingstone, Philadelphia 108
29. Weber R., Schlagenhauf P., Amsler L., and Steffen R. Knowledge, attitudes and practices of business travellers regarding malaria risk and prevention. J Travel Med 10 4 (2003) 219-224
30. Dondorp A.M., Newton P.N., Mayxay M., et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 9 12 (2004) 1241-1246
31. Marra F., Salzman J.R., and Ensom M.H. Atovaquone-proguanil for prophylaxis and treatment of malaria. Ann Pharmacother 37 9 (2003) 1266-1275
32. Karbwang J., and White N.J. Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 19 4 (1990) 264-279
33. Kofoed K., and Petersen E. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travellers from Denmark. J Travel Med 10 3 (2003) 150-154
34. Strauss R., and Pfeifer C. Malaria in Austria 1990-2000. Euro Surveill 8 4 (2003) 91-96
35. Kollaritsch H., Que J.U., Kunz C., Wiedermann G., Herzog C., and Cryz Jr. S.J. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J Infect Dis 175 4 (1997) 871-875
36. Rosen J.B., and Breman J.G. Malaria intermittent preventive treatment in infants, chemoprophylaxis, and childhood vaccinations. Lancet 363 9418 (2004) 1386-1388
37. Rosen J.B., Breman J.G., Manclark C.R., Meade B.D., Collins W.E., Lobel H.O., et al. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines. Malar J 4 1 (2005) 53
38. Baird J.K., Fryauff D.J., and Hoffman S.L. Primaquine for prevention of malaria in travellers. Clin Infect Dis 37 12 (2003) 1659-1667 Epub 2003 Nov 20
39. Klement E., Chauveheid M.P., Thellier M., Bricaire F., Danis M., and Caumes E. Subacute clinical forms of Plasmodium falciparum malaria in travellers receiving Chloroquine-Proguanil prophylaxis. Clin Infect Dis 33 1 (2001) e1-e2 Epub 2001 May 23
40. Warhurst D.C., Steele J.C., Adagu I.S., Craig J.C., and Cullander C. Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. J Antimicrob Chemother J Antimicrob Chemother 52 2 (2003) 188-193 Epub 2003 Jul 1
41. British National Formulary: Appendix 3, number 50/September 2005. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2005.
42. Croft A.M., Whitehouse D.P., Cook G.C., and Beer M.D. Safety evaluation of the drugs available to prevent malaria. Expert Opin Drug Saf 1 1 (2002) 19-27
43. Camus D., Djossou F., Schilthuis H.J., Hogh B., Dutoit E., Malvy D., et al. International Malarone Study Team. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travellers: results of an international, randomized, open-label study. Clin Infect Dis 38 12 (2004) 1716-1723 Epub 2004 May 27
44. Taylor W.R., and White N.J. Antimalarial drug toxicity: a review. Drug Saf 27 1 (2004) 25-61
45. Croft A.M., and Garner P. Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev 3 (2000) CD000138
46. Fonteyne W., Bauwens A., and Jordaens L. Atrial flutter with 1:1 conduction after administration of the antimalarial drugMefloquine. Clin Cardiol 19 12 (1996) 967-968
47. van Riemsdijk M.M., Sturkenboom M.C., Ditters J.M., Tulen J.H., Ligthelm R.J., Overbosch D., et al. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. Br J Clin Pharmacol 57 4 (2004) 506-512
48. Phillips-Howard P.A., Steffen R., Kerr L., Vanhauwere B., Schildknecht J., Fuchs E., et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 5 3 (1998) 121-126
49. Smoak B.L., Writer J.V., Keep L.W., Cowan J., and Chantelois J.L. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 176 3 (1997) 831-833
50. Na-Bangchang K., Manyando C., Ruengweerayut R., Kioy D., Mulenga M., Miller G.B., et al. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Eur J Clin Pharmacol 61 8 (2005) 573-582 Epub 2005 Jul 23
51. Suh K.N., and Mileno M.D. Challenging scenarios in a travel clinic: advising the complex traveler. Infect Dis Clin North Am 19 1 (2005) 15-47
52. Shanks G.D., Oloo A.J., Aleman G.M., et al. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clin Infect Dis 33 (2001) 1968
53. Walsh D.S., Eamsila C., Sasiprapha T., et al. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. J Infect Dis 190 (2004) 1456
54. Traebert M., and Dumotier B. Antimalarial drugs: QT prolongation and cardiac arrhythmias. Expert Opin Drug Saf 4 3 (2005) 421-431
55. Office for National Statistics. Travel trends: a report on the 2003 International Passenger Survey. 2004.
56. Hughes C., Tucker R., Bannister B., and Bradley D.J. Health Protection Agency Advisory Committee on Malaria Prevention for UK Travellers. Malaria prophylaxis for long-term travellers. Commun Dis Public Health 6 3 (2003) 200-208
57. Greenwood B. Malaria vaccines. Evaluation and implementation. Acta Trop 95 3 (2005) 298-304
58. Snounou G., Gruner A.C., Muller-Graf C.D., Mazier D., and Renia L. The Plasmodium sporozoite survives RTS,S vaccination. Trends Parasitol 21 10 (2005) 456-461
59. Miller K.K., and Banerji A. Epidemiology of malaria presenting at British Columbia's Children's Hospital, 1984-2001: lessons for prevention. Can J Public Health 95 4 (2004) 245-248
60. Jain S.K., Persaud D., Perl T.M., et al. Nosocomial malaria and saline flush. Emerg Infect Dis 11 7 (2005) 1097-1099
61. Moro M.L., Romi R., Severini C., Casadio G.P., Sarta G., Tampieri G., et al. Malaria Outbreak Group. Patient-to-patient transmission of nosocomial malaria in Italy. Infect Control Hosp Epidemiol 23 6 (2002) 338-341
62. Microscopic procedures for diagnosing malaria. Appendix. MMWR Surveillance Summaries. June 3, 2005 / 54(SS02);39-40.
63. Durrheim D.N., Becker P.J., and Billinghurst K. Diagnostic disagreement-the lessons learnt from malaria diagnosis in Mpumalanga. S Afr Med J 87 8 (1997) 1016
64. Kain K.C., Harrington M.A., Tennyson S., and Keystone J.S. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 27 1 (1998) 142-149
65. ®.
66. Lema O.E., Carter J.Y., Nagelkerke N., Wangai M.W., Kitenge P., Gikunda S.M., et al. Comparison of five methods of malaria detection in the outpatient setting. Am J Trop Med Hyg 60 2 (1999) 177-182
67. Swan H., Sloan L., Muyombwe A., Chavalitshewinkoon-Petmitr P., Krudsood S., Leowattana W., et al. Evaluation of a real-time polymerase chain reaction assay for the diagnosis of malaria in patients from Thailand. Am J Trop Med Hyg 73 5 (2005) 850-854
68. Mangold K.A., Manson R.U., Koay E.S., Stephens L., Regner M., Thomson Jr. R.B., et al. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol 43 5 (2005) 2435-2440
69. Ciceron L., Jaureguiberry G., Gay F., and Danis M. Development of a Plasmodium PCR for monitoring efficacy of antimalarial treatment. J Clin Microbiol 37 1 (1999) 35-38
70. Moody A.H., and Chiodini P.L. Non-microscopic method for malaria diagnosis using OptiMAL IT, a second-generation dipstick for malaria pLDH antigen detection. Br J Biomed Sci 59 4 (2002) 228-231
71. Forney J.R., Wongsrichanalai C., Magill A.J., et al. Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol 41 6 (2003) 2358-2366
72. Murray C.K., Bell D., Gasser R.A., and Wongsrichanalai C. Rapid diagnostic testing for malaria. Trop Med Int Health 8 10 (2003) 876-883
73. Hanscheid T. Diagnosis of malaria: a review of alternatives to conventional microscopy. Clin Lab Haematol 21 4 (1999) 235-245
74. Wongsrichanalai C. Rapid diagnostic techniques for malaria control. Trends Parasitol 17 7 (2001) 307-309
75. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 15 1 (2002) 66-78
76. Marx A., Pewsner D., Egger M., Nuesch R., Bucher H.C., Genton B., et al. Meta-analysis: accuracy of rapid tests for malaria in travellers returning from endemic areas. Ann Intern Med 142 10 (2005) 836-846
77. Wever P.C., Henskens Y.M., Kager P.A., Dankert J., and van Gool T. Detection of imported malaria with the Cell-Dyn 4000 hematology analyzer. J Clin Microbiol 40 12 (2002) 4729-4731
78. Svenson J.E., MacLean J.D., Gyorkos T.W., and Keystone J. Imported malaria. Clinical presentation and examination of symptomatic travellers. Arch Intern Med 155 8 (1995) 861-868
79. White N.J. Antimalarial Drug Resistance. J Clin Invest 113 8 (2004) 1084-1092
80. Badiaga S., Brouqui P., Carpentier J.P., Hovette P., Duigou F., Manelli J.C., et al. Severe imported malaria: Clinical presentation at the time of hospital admission and outcome in 42 cases diagnosed from 1996 to 2002. J Emerg Med 29 4 (2005) 375-382
81. Antinori S., Galimberti L., Gianelli E., Calattini S., Piazza M., Morelli P., et al. Prospective observational study of fever in hospitalized returning travellers and migrants from tropical areas, 1997-2001. J Travel Med 11 3 (2004) 135-142
82. Drugs for Parasitic Infections, The Medical Letter on Drugs and Therapeutics, August 2004, http://www.medletter.com/freedocs/parasitic.pdf.
83. Woodrow C.J., Haynes R.K., and Krishna S. Artemisinins. Postgrad Med J 81 952 (2005) 71-78
84. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., and Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2 4 (2002) 209-218
85. Looareesuwan S., Chulay J.D., Canfield C.J., and Hutchinson D.B. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg 60 4 (1999) 533-541
86. Looareesuwan S., Wilairatana P., Chalermarut K., Rattanapong Y., Canfield C.J., and Hutchinson D.B. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg 60 4 (1999) 526-532
87. ter Kuile F., White N.J., Holloway P., Pasvol G., and Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol 76 (1993) 85-95
88. Toovey S., and Jamieson A. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 98 5 (2004) 261-267 discussion 268-9
89. Looareesuwan S., Viravan C., Vanijanonta S., Wilairatana P., Suntharasamai P., Charoenlarp P., et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339 8797 (1992) 821-824
90. Campbell P., Baruah S., Narain K., and Rogers C.C. A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India. Trans R Soc Trop Med Hyg 11 (2005) [Epub ahead of print]
91. Omari A., Gamble C., Garner P., and Omari A. Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev 4 (2005) CD005564
92. Dondorp A., Nosten F., Stepniewska K., Day N., and White N. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366 9487 (2005) 717-725
93. Bukirwa H., Orton L., and Bukirwa H. Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria. Cochrane Database Syst Rev 4 (2005) CD004531
94. Sumawinata I.W., Bernadeta B.L., Sutamihardja A., Purnomo B.S., Sekartuti D.J.F., and Baird J.K. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg 68 4 (2003) 416-420
95. Tjitra E., Baker J., Suprianto S., Cheng Q., and Anstey N.M. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob Agents Chemother 46 12 (2002) 3947-3953
96. Myat-Phone-Kyaw, Myint-Oo, Aung-Naing, and Aye-Lwin-Htwe. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar. Southeast Asian J Trop Med Public Health 25 4 (1994) 710-713
97. Shulman C.E., and Dorman E.K. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 97 1 (2003) 30-35
98. Orton L., and Garner P. Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 3 (2005) CD004912
99. Adam I., Mirghani O.A., Saed O.K., et al. Quinine therapy in severe Plasmodium falciparum malaria during pregnancy in Sudan. East Mediterr Health J 10 1-2 (2004) 159-166
100. Nosten F., Vincenti M., Simpson J., Yei P., Thwai K.L., de Vries A., et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 28 4 (1999) 808-815
101. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 Suppl 1 (2000) S1-S90
102. Geoffrey Pasvol. Malaria. In: Cohen & Powderly, Infectious Diseases, 2nd ed.Mosby. 2004.
103. Hien T.T., Phu N.H., Mai N.T., Chau T.T., Trang T.T., Loc P.P., et al. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria. Trans R Soc Trop Med Hyg 86 6 (1992) 584-585
104. Hien T.T., Arnold K., Vinh H., Cuong B.M., Phu N.H., Chau T.T., et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 86 6 (1992) 582-583
105. Tran T.H., Day N.P., Nguyen H.P., Nguyen T.H., Tran T.H., Pham P.L., et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335 2 (1996) 76-83
106. Ashley E.A., and White N.J. Artemisinin-based combinations. Curr Opin Infect Dis 18 6 (2005) 531-536
107. Aceng J.R., Byarugaba J.S., and Tumwine J.K. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. BMJ 330 7487 (2005) 334
108. Olliaro P.L., and Taylor W.R. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review. J Postgrad Med 50 1 (2004) 40-44